NASDAQ: ALZNAlzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?
Insider buying vs selling
Have Alzamend Neuro Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Milton C. Ault Iii | Director | 2026-08-26 | 2,000 | $1.56 | $3.12kSell |
| Milton C. Ault Iii | Director | 2026-04-14 | 108,388 | $1.01 | $108.93kBuy |
| Milton C. Ault Iii | Director | 2026-04-14 | 108,388 | $1.01 | $108.93kBuy |
| Milton C. Ault Iii | Director | 2026-04-14 | 2,000 | $1.03 | $2.07kBuy |
| Milton C. Ault Iii | Director | 2026-04-14 | 108,388 | $1.01 | $108.93kBuy |
| Milton C. Ault Iii | Director | 2026-04-14 | 2,000 | $1.03 | $2.07kBuy |
| Milton C. Ault Iii | Director | 2025-12-23 | 1,851 | $2.07 | $3.83kSell |
| William B. Horne | Director | 2025-12-19 | 3,333 | $2.12 | $7.06kSell |
ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ALZN insiders and whales buy or sell their stock.
ALZN Shareholders
What type of owners hold Alzamend Neuro Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Milton C. Ault Iii | 730.28% | 35,241,237 | $42.64M | Insider |
| Jeffrey Oram | 2.07% | 100,000 | $121.00k | Insider |
| Andrew H. Woo | 2.07% | 100,000 | $121.00k | Insider |
| Mark Gustafson | 1.24% | 60,000 | $72.60k | Insider |
| Stephan Jackman | 0.94% | 45,500 | $55.06k | Insider |
| David J. Katzoff | 0.11% | 5,540 | $6.70k | Insider |
| Kmtwea | 0.03% | 1,329 | $1.61k | Institution |
| Kmt Wealth Management LLC | 0.03% | 1,329 | $1.61k | Institution |
| Kingsbury Capital Investment Advisors LLC | 0.03% | 1,329 | $1.61k | Institution |
| Geode Capital Management LLC | 0.00% | 26 | $31.46 | Institution |
ALZN vs Biotech Stocks
Alzamend Neuro Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.